Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in Systemic Lupus Erythematosus patients

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Garcia Rodriguez, Sonia ^a   Callejas Rubio, Jose Luis ^b   Ortego Centeno, Norberto ^b   Zumaquero, Esther ^a,c   Ríos Fernandez, Raquel ^b   Arias Santiago, Salvador ^d   Navarro, Pilar ^a   Sancho, Jaime ^a   Zubiaur, Mercedes ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c University of Alabama at Birmingham   (United States)

^d SCUH   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN KINASE B; RETINOIC ACID RELATED ORPHAN RECEPTOR; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; CALGRANULIN A; CALGRANULIN B; CYTOKINE; INTERLEUKIN 1; MAPK1 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; UPREGULATION; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MURINAE;

ADULT; CALGRANULIN A; CALGRANULIN B; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84869020815     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/495934     Document Type: Article

References (106)

1. Cervera R., Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the 'Euro-Lupus Project' Autoimmunity Reviews 2006 5 3 180 186 2-s2.0-32544444877 10.1016/j.autrev.2005.06.004 (Pubitemid 43234182)
2. Perl A., Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity 2010 43 1 1 6 2-s2.0-75749095952 10.3109/08916930903374741
3. Jenks S. A., Sanz I., Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmunity Reviews 2009 8 3 209 213 2-s2.0-58149214308 10.1016/j.autrev.2008.07.047
4. Crispín J. C., Kyttaris V. C., Terhorst C., Tsokos G. C., T cells as therapeutic targets in SLE. Nature Reviews Rheumatology 2010 6 6 317 325 2-s2.0-77953229472 10.1038/nrrheum.2010.60
5. Tsokos G. C., Systemic lupus erythematosus. The New England Journal of Medicine 2011 365 2110 2121
6. Nakou M., Bertsias G., Stagakis I., Centola M., Tassiulas I., Hatziapostolou M., Kritikos I., Goulielmos G., Boumpas D. T., Iliopoulos D., Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS ONE 2010 5 10 2-s2.0-78149457487 10.1371/journal.pone.0013351 e13351
7. Juntilla M. M., Koretzky G. A., Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunology Letters 2008 116 2 104 110 2-s2.0-40149099723 10.1016/j.imlet.2007.12.008
8. Finlay D., Cantrell D. A., Metabolism, migration and memory in cytotoxic T cells. Nature Reviews Immunology 2011 11 2 109 117 2-s2.0-79151486083 10.1038/nri2888
9. Bononi A., Agnoletto C., De Marchi E., Protein kinases and phosphatases in the control of cell fate. Enzyme Research 2011 2011 26 329098 10.4061/2011/329098
10. Macintyre A. N., Finlay D., Preston G., Sinclair L. V., Waugh C. M., Tamas P., Feijoo C., Okkenhaug K., Cantrell D. A., Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 2011 34 2 224 236 2-s2.0-79951745387 10.1016/j.immuni.2011.01.012
11. Taher T. E., Parikh K., Flores-Borja F., Mletzko S., Isenberg D. A., Peppelenbosch M. P., Mageed R. A., Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus. Arthritis and Rheumatism 2010 62 8 2412 2423 2-s2.0-77955373398 10.1002/art.27505
12. Gorelik G., Richardson B., Key role of ERK pathway signaling in lupus. Autoimmunity 2010 43 1 17 22 2-s2.0-75749090357 10.3109/08916930903374832
13. Molad Y., Amit-Vasina M., Bloch O., Yona E., Rapoport M. J., Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2010 69 1 175 180 2-s2.0-73449141813 10.1136/ard.2008.102780
14. Sawalha A. H., Jeffries M., Webb R., Lu Q., Gorelik G., Ray D., Osban J., Knowlton N., Johnson K., Richardson B., Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes and Immunity 2008 9 4 368 378 2-s2.0-44849087740 10.1038/gene.2008.29 (Pubitemid 351791493)
15. Krishnan S., Juang Y. T., Chowdhury B., Magilavy A., Fisher C. U., Nguyen H., Nambiar M. P., Kyttaris V., Weinstein A., Bahjat R., Pine P., Rus V., Tsokos G. C., Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. Journal of Immunology 2008 181 11 8145 8152 2-s2.0-58149308537
16. Apostolidis S. A., Lieberman L. A., Kis-Toth K., The dysregulation of cytokine networks in systemic lupus erythematosus. Journal of Interferon & Cytokine Research 2011 31 769 779
17. Jacob N., Stohl W., Cytokine disturbances in systemic lupus erythematosus. Arthritis Research & Therapy 2011 13, article 228
18. Kariuki S. N., Niewold T. B., Genetic regulation of serum cytokines in systemic lupus erythematosus. Translational Research 2010 155 3 109 117 2-s2.0-76549136591 10.1016/j.trsl.2009.08.012
19. Su D. L., Lu Z. M., Shen M. N., Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. Journal of Biomedicine and Biotechnology 2012 2012 15 10.1155/2012/347141 347141
20. Yu S. L., Kuan W. P., Wong C. K., Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 14 715190 10.1155/2012/715190
21. Zhu J., Paul W. E., Heterogeneity and plasticity of T helper cells. Cell Research 2010 20 1 4 12 2-s2.0-73849110167 10.1038/cr.2009.138
22. Nakayamada S., Takahashi H., Kanno Y., Helper T cell diversity and plasticity. Current Opinion in Immunology 2012 24 297 302
23. Chan R. W. Y., Lai F. M. M., Li E. K. M., Tam L. S., Chow K. M., Li P. K. T., Szeto C. C., Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology 2006 45 8 951 957 2-s2.0-33746930141 10.1093/rheumatology/kel029 (Pubitemid 44283048)
24. Garcia-Rodriguez S., Arias-Santiago S., Perandres-Lopez R., Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. In press 10.1111/j.1468-3083.2011.04372
25. Chung B. H., Oh H. J., Piao S. G., Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection. Immunology 2012 136 3 344 351
26. Miyake K., Akahoshi M., Nakashima H., Th subset balance in lupus nephritis. Journal of Biomedicine and Biotechnology 2011 2011 7 980286 10.1155/2011/980286
27. Soyfoo M. S., Roth J., Vogl T., Pochet R., Decaux G., Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. Journal of Rheumatology 2009 36 10 2190 2194 2-s2.0-70450179808 10.3899/jrheum.081302
28. Lood C., Stenström M., Tydén H., Gullstrand B., Källberg E., Leanderson T., Truedsson L., Sturfelt G., Ivars F., Bengtsson A. A., Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Research and Therapy 2011 13 2, article R60 2-s2.0-79953889854 10.1186/ar3314
29. Pavon E. J., Garcia-Rodriguez S., Zumaquero E., Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes. Journal of Proteomics 2012 75 6 1778 91
30. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H., Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis and Rheumatism 1992 35 6 630 640 2-s2.0-0026777352 10.1002/art.1780350606
31. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis and Rheumatism 1982 25 11 1271 1277 2-s2.0-0020436689 (Pubitemid 13221242)
32. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
33. + T-cell differentiation regulated by networks of cytokines and transcription factors. Immunological Reviews 2010 238 1 247 262 2-s2.0-77958611660 10.1111/j.1600-065X.2010.00951.x
34. Wing J. B., Sakaguchi S., Multiple treg suppressive modules and their adaptability. Frontiers in Immunology 2012 3 178
35. Haga H. J., Brun J. G., Berntzen H. B., Cervera R., Khamashta M., Hughes G. R. V., Calprotection in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993 2 1 47 50 2-s2.0-0027340150 (Pubitemid 23115237)
36. Wei L., Vahedi G., Sun H. W., Watford W. T., Takatori H., Ramos H. L., Takahashi H., Liang J., Gutierrez-Cruz G., Zang C., Peng W., O'Shea J. J., Kanno Y., Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 2010 32 6 840 851 2-s2.0-77953917067 10.1016/j.immuni.2010.06.003
37. Salmond R. J., Emery J., Okkenhaug K., Zamoyska R., MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells. Journal of Immunology 2009 183 11 7388 7397 2-s2.0-73349119966 10.4049/jimmunol.0902294
38. + human memory T cells. The Journal of Experimental Medicine 2011 208 1875 1887
39. Kurebayashi Y., Nagai S., Ikejiri A., PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Reports 2012 1 360 373
40. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z. A., Cobb B. S., Cantrell D., O'Connor E., Shokat K. M., Fisher A. G., Merkenschlager M., T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7797 7802 2-s2.0-45549098562 10.1073/pnas. 0800928105 (Pubitemid 351872718)
41. Arimura Y., Shiroki F., Kuwahara S., Kato H., Dianzani U., Uchiyama T., Yagi J., Akt is a neutral amplifier for Th cell differentiation. The Journal of Biological Chemistry 2004 279 12 11408 11416 2-s2.0-1642524215 10.1074/jbc.M309063200 (Pubitemid 38401640)
42. Okkenhaug K., Patton D. T., Bilancio A., Garon F., Rowan W. C., Vanhaesebroeck B., The p110 δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. Journal of Immunology 2006 177 8 5122 5128 2-s2.0-33749515632 (Pubitemid 44527583)
43. Suarez-Fueyo A., Barber D. F., Martinez-Ara J., Enhanced phosphoinositide 3-kinase delta activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death. The Journal of Immunology 2011 187 2376 2385
44. Morel J., Audo R., Hahne M., Combe B., Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. The Journal of Biological Chemistry 2005 280 16 15709 15718 2-s2.0-18144416502 10.1074/jbc.M414469200 (Pubitemid 40616690)
45. Komatsuda A., Wakui H., Iwamoto K., Togashi M., Maki N., Masai R., Hatakeyama T., Sawada K., Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus. Clinical Immunology 2007 125 1 26 29 2-s2.0-34548476965 10.1016/j.clim.2007.05. 019 (Pubitemid 47374538)
46. Huang S. C., Tsai H. F., Tzeng H. T., Liao H. J., Hsu P. N., Lipid raft assembly and LcK recruitment in TRAIL costimulation mediates NF- κ B activation and T cell proliferation. Journal of Immunology 2011 186 2 931 939 2-s2.0-79251560943 10.4049/jimmunol.1001092
47. Fischer A. M., Katayama C. D., Pagès G., Pouysségur J., Hedrick S. M., The role of Erk1 and Erk2 in multiple stages of T cell development. Immunity 2005 23 4 431 443 2-s2.0-26644459229 10.1016/j.immuni. 2005.08.013 (Pubitemid 41443444)
48. von Kriegsheim A., Baiocchi D., Birtwistle M., Sumpton D., Bienvenut W., Morrice N., Yamada K., Lamond A., Kalna G., Orton R., Gilbert D., Kolch W., Cell fate decisions are specified by the dynamic ERK interactome. Nature Cell Biology 2009 11 12 1458 1464 2-s2.0-73349139547
49. Zhu Y., Bertics P. J., Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils. Journal of Immunology 2011 186 1 516 526 2-s2.0-79251575558 10.4049/jimmunol.1000955
50. Arasappan D., Tong W., Mummaneni P., Fang H., Amur S., Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Medicine 2011 9, article 65 2-s2.0-79957541792 10.1186/1741-7015-9- 65
51. Gateva V., Sandling J. K., Hom G., Taylor K. E., Chung S. A., Sun X., Ortmann W., Kosoy R., Ferreira R. C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jönsen A., Bengtsson A. A., Rantapää-Dahlqvist S., Baechler E. C., Brown E. E., Alarcón G. S., Edberg J. C., Ramsey-Goldman R., McGwin G., Reveille J. D., Vilá L. M., Kimberly R. P., Manzi S., Petri M. A., Lee A., Gregersen P. K., Seldin M. F., Rönnblom L., Criswell L. A., Syvänen A. C., Behrens T. W., Graham R. R., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 2009 41 11 1228 1233 2-s2.0-70350650472 10.1038/ng.468
52. Li M. O., Flavell R. A., Contextual regulation of inflammation: a duet by transforming growth factor- β and interleukin-10. Immunity 2008 28 4 468 476 2-s2.0-41549169557 10.1016/j.immuni.2008.03.003 (Pubitemid 351467045)
53. Ouyang W., Rutz S., Crellin N. K., Valdez P. A., Hymowitz S. G., Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 2011 29 71 109 2-s2.0-79953048089 10.1146/annurev-immunol-031210-101312
54. Saraiva M., O'Garra A., The regulation of IL-10 production by immune cells. Nature Reviews Immunology 2010 10 3 170 181 2-s2.0-77649184739 10.1038/nri2711
55. Carter N. A., Vasconcellos R., Rosser E. C., Tulone C., Muoz-Suano A., Kamanaka M., Ehrenstein M. R., Flavell R. A., Mauri C., Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. Journal of Immunology 2011 186 10 5569 5579 2-s2.0-79956224216 10.4049/jimmunol.1100284
56. Saraiva M., Christensen J. R., Veldhoen M., Murphy T. L., Murphy K. M., O'Garra A., Interleukin-10 production by Th1 cells requires interleukin-12- induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009 31 2 209 219 2-s2.0-68649116551 10.1016/j.immuni.2009.05. 012
57. Grant L. R., Yao Z. J., Hedrich C. M., Wang F., Moorthy A., Wilson K., Ranatunga D., Bream J. H., Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes and Immunity 2008 9 4 316 327 2-s2.0-44849133855 10.1038/gene.2008.20 (Pubitemid 351791487)
58. McGeachy M. J., Bak-Jensen K. S., Chen Y., Tato C. M., Blumenschein W., McClanahan T., Cua D. J., TGF- β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nature Immunology 2007 8 12 1390 1397 2-s2.0-36248965294 10.1038/ni1539 (Pubitemid 350138974)
59. Avagyan S., Aguilo-Payeras F., Kamezaki K., Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-beta2 and FLT3 in hematopoiesis. Blood 2011 118 6078 6086
60. Astier A. L., Beriou G., Eisenhaure T. M., Anderton S. M., Hafler D. A., Hacohen N., RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. Journal of Immunology 2010 184 2 685 693 2-s2.0-76249116970 10.4049/jimmunol.0902443
61. Lopez P., Gutierrez C., Suarez A., IL-10 and TNFalpha genotypes in SLE. Journal of Biomedicine and Biotechnology 2010 2010 838390
62. Smallie T., Ricchetti G., Horwood N. J., Feldmann M., Clark A. R., Williams L. M., IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. Journal of Experimental Medicine 2010 207 10 2081 2088 2-s2.0-77957726025 10.1084/jem.20100414
63. Zubiaur M., Fernández O., Ferrero E., Salmerón J., Malissen B., Malavasi F., Sancho J., CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3- ζ immune receptor tyrosine-based activation motifs. Journal of Biological Chemistry 2002 277 1 13 22 2-s2.0-0037016731 10.1074/jbc.M107474200 (Pubitemid 34952022)
64. Zumaquero E., Muoz P., Cobo M., Lucena G., Pavón E. J., Martín A., Navarro P., García-Pérez A., Ariza-Veguillas A., Malavasi F., Sancho J., Zubiaur M., Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn. Experimental Cell Research 2010 316 16 2692 2706 2-s2.0-77955845525 10.1016/j.yexcr.2010.05.032
65. Patton D. T., Wilson M. D., Rowan W. C., Soond D. R., Okkenhaug K., The PI3K p110 δ regulates expression of CD38 on regulatory T cells. PLoS ONE 2011 6 3 2-s2.0-79952292365 10.1371/journal.pone.0017359 e17359
66. + CD24 hi CD38 hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010 32 1 129 140 2-s2.0-74649083783 10.1016/j.immuni.2009.11.009
67. Chaudhry A., Samstein R. M., Treuting P., Liang Y., Pils M. C., Heinrich J. M., Jack R. S., Wunderlich F. T., Brüning J. C., Müller W., Rudensky A. Y., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011 34 4 566 578 2-s2.0-79954608612 10.1016/j.immuni.2011.03.018
68. + T cells in an interleukin-10-dependent manner. Immunity 2011 34 4 554 565 2-s2.0-79954620910 10.1016/j.immuni.2011.01.020
69. Rudensky A. Y., Regulatory T cells and Foxp3. Immunological Reviews 2011 241 1 260 268 2-s2.0-79954486763 10.1111/j.1600-065X.2011.01018.x
70. + Treg in SLE patients: a heritable trait associated with CTLA4 and TGF β gene variants. BMC Immunology 2009 10, article 5 2-s2.0-63049113003 10.1186/1471-2172-10-5
71. Suggs M. J. L., Majithia V., Lewis R. E., Cruse J. M., HLA DRB11503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus. Experimental and Molecular Pathology 2011 91 2 548 562 2-s2.0-79960324944 10.1016/j.yexmp.2011.03.006
72. + regulatory T cells (TREG) in Systemic Lupus Erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clinical Immunology 2008 127 2 151 157 2-s2.0-41549153318 10.1016/j.clim.2007.12.010
73. Prado C., Gómez J., López P., de Paz B., Gutiérrez C., Suárez A., Dexamethasone upregulates FOXP3 expression without increasing regulatory activity. Immunobiology 2011 216 3 386 392 2-s2.0-79251595110 10.1016/j.imbio.2010.06.013
74. Sbiera S., Dexneit T., Reichardt S. D., Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS ONE 2011 6 e24345
75. + T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells. Rheumatology 2011 50 4 646 656 2-s2.0-79952787680 10.1093/rheumatology/keq328
76. Murphy K. M., Stockinger B., Effector T cell plasticity: flexibility in the face of changing circumstances. Nature Immunology 2010 11 8 674 680 2-s2.0-77954948735 10.1038/ni.1899
77. + CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. Journal of Immunology 2007 178 4 2579 2588 2-s2.0-33846900430 (Pubitemid 46233461)
78. + T cells in lupus patients. Clinical Rheumatology 2010 29 11 1251 1258 2-s2.0-77957690846 10.1007/s10067-010-1510-7
79. + Treg cells decrease in patients with lupus nephritis. Rheumatology International 2011 32 4 949 958 2-s2.0-78651360627 10.1007/s00296-010-1771-0
80. Chapoval S., Dasgupta P., Dorsey N. J., Keegan A. D., Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. Journal of Leukocyte Biology 2010 87 6 1011 1018 2-s2.0-77953991456 10.1189/jlb.1209772
81. Wang Y., Su M. A., Wan Y. Y., An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011 35 337 348
82. Shah K., Lee W. W., Lee S. H., Kim S. H., Kang S. W., Craft J., Kang I., Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Research and Therapy 2010 12 2, article R53 2-s2.0-77955177322 10.1186/ar2964
83. Sallusto F., Kremmer E., Palermo B., Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. European Journal of Immunology 1999 29 2037 2045 (Pubitemid 29265560)
84. Prado C., de Paz B., Gomez J., Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients. Rheumatology 2011 50 1794 1801
85. + cells in SLE. Arthritis Research & Therapy 2010 12 1 101 2-s2.0-77955478585
86. + T cells. Current Opinion in Immunology 2009 21 3 281 285 2-s2.0-67049168780 10.1016/j.coi.2009.05.007
87. Lu L., Zhou X., Wang J., Zheng S. G., Horwitz D. A., Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF- β and retinoic acid. PloS ONE 2010 5 12 e15150 2-s2.0-79960141313
88. Hale M. B., Krutzik P. O., Samra S. S., Crane J. M., Nolan G. P., Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS ONE 2009 4 8 2-s2.0-69449090795 10.1371/journal.pone. 0006756 e6756
89. Cash H., Relle M., Menke J., Brochhausen C., Jones S. A., Topley N., Galle P. R., Schwarting A., Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Fas lpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Journal of Rheumatology 2010 37 1 60 70 2-s2.0-73649123508 10.3899/jrheum.090194
90. Chun H. Y., Chung J. W., Kim H. A., Yun J. M., Jeon J. Y., Ye Y. M., Kim S. H., Park H. S., Suh C. H., Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. Journal of Clinical Immunology 2007 27 5 461 466 2-s2.0-34548223736 10.1007/s10875-007-9104-0 (Pubitemid 47319257)
91. Hu S., Xiao W., Kong F., Ke D., Qin R., Su M., Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus. Journal of Huazhong University of Science and Technology 2008 28 5 549 552 2-s2.0-58449085295 10.1007/s11596-008-0513-y
92. Ohl K., Tenbrock K., Inflammatory cytokines in systemic lupus erythematosus. Journal of Biomedicine and Biotechnology 2011 2011 14 432595 10.1155/2011/432595
93. Sabry A., sheashaa H., El-husseini A., Mahmoud K., Eldahshan K. F., George S. K., Abdel-Khalek E., El-Shafey E. M., Abo-Zenah H., Proinflammatory cytokines (TNF- α and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006 35 3-4 148 153 2-s2.0-33750516949 10.1016/j.cyto.2006.07.023 (Pubitemid 44666430)
94. Naugler W. E., Karin M., The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine 2008 14 3 109 119 2-s2.0-40649109728 10.1016/j.molmed.2007.12.007
95. Sonoda E., Matsumoto R., Hitoshi Y., Ishii T., Sugimoto M., Araki S., Tominaga A., Yamaguchi N., Takatsu K., Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. The Journal of Experimental Medicine 1989 170 4 1415 1420 2-s2.0-0024445451 (Pubitemid 19250703)
96. Hayashi T., Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN- λ targeting gene therapy. Journal of Biomedicine and Biotechnology 2010 2010 19 2-s2.0-77956844800 10.1155/2010/461641 461641
97. Erickson L. D., Foy T. M., Waldschmidt T. J., Murine B1 B cells require IL-5 for optimal T cell-dependent activation. Journal of Immunology 2001 166 3 1531 1539 2-s2.0-0035253560 (Pubitemid 32114632)
98. Martin F., Kearney J. F., B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a ″ natural immune memory ″ Immunological Reviews 2000 175 70 79 2-s2.0-0033919320 10.1034/j.1600-065X.2000.017515.x (Pubitemid 30427157)
99. Koyasu S., Moro K., Type 2 innate immune responses and the natural helper cell. Immunology 2011 132 4 475 481 2-s2.0-79952531912 10.1111/j.1365-2567. 2011.03413.x
100. Wen X., Zhang D., Kikuchi Y., Jiang Y., Nakamura K., Xiu Y., Tsurui H., Takahashi K., Abe M., Ohtsuji M., Nishimura H., Takatsu K., Shirai T., Hirose S., Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. European Journal of Immunology 2004 34 10 2740 2749 2-s2.0-7244229674 10.1002/eji.200425267 (Pubitemid 39430151)
101. Valeyev N. V., Hundhausen C., Umezawa Y., Kotov N. V., Williams G., Clop A., Ainali C., Ouzounis C., Tsoka S., Nestle F. O., A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Computational Biology 2010 6 12 2-s2.0-78651250747 10.1371/journal.pcbi.1001024 e1001024
102. Capper E. R., Maskill J. K., Gordon C., Blakemore A. I. F., Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? Clinical and Experimental Immunology 2004 138 2 348 356 2-s2.0-8144224559 10.1111/j.1365-2249.2004.02607.x (Pubitemid 39472455)
103. Rhodes B., Meek J., Whittaker J. C., Vyse T. J., Quantification of the genetic component of basal C-reactive protein expression in SLE nuclear families. Annals of Human Genetics 2008 72 5 611 620 2-s2.0-45049087658 10.1111/j.1469-1809.2008.00444.x
104. Meinl E., Lengenfelder D., Blank N., Pirzer R., Barata L., Hivroz C., Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature T cells. Journal of Immunology 2000 165 7 3578 3583 2-s2.0-0034292373 (Pubitemid 32057259)
105. Foell D., Wittkowski H., Vogl T., Roth J., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 2007 81 1 28 37 2-s2.0-33845868493 10.1189/jlb.0306170 (Pubitemid 46021248)
106. Urban C. F., Ermert D., Schmid M., Abu-Abed U., Goosmann C., Nacken W., Brinkmann V., Jungblut P. R., Zychlinsky A., Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathogens 2009 5 10 2-s2.0-73649099522 10.1371/journal.ppat.1000639 e1000639